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Abstract  
Purpose: This prospective study was conducted to assess the influence of overnight 
orthokeratology (OK) on axial length elongation in children, with those wearing spectacles as 
controls.  
Methods: One hundred five subjects (210 eyes) were enrolled in this study. The OK group 
comprised 45 patients (90 eyes, age 12.1 ± 2.5 years, mean ± SD) (OK group) who matched the 
inclusion criteria for OK. The control group comprised 60 patients (120 eyes, 11.9 ± 2.0 years) 
who also matched the inclusion criteria for OK but preferred spectacles for myopia correction. 
Axial length was measured at baseline and after 2 years using the IOLMaster (Zeiss Humphrey 
System, CA, USA) and the changes were evaluated and compared between the groups.  
Results: Ninety two subjects (42 and 50 in the OK and control groups, respectively) completed 
the 2-year follow-up examinations. At baseline, the spherical equivalent refractive error was 
-2.55 ± 1.82 D and -2.59 ± 1.66 D, and the axial length was 24.66 ± 1.11 mm and 24.79 ± 0.80 
mm in the OK and control groups, respectively, with no significant differences between the 
groups. The increase in axial length during the 2-year study period was 0.39 ± 0.27 mm and 0.61 
± 0.24 mm, respectively, and the difference was significant (P < 0.0001, unpaired t test).  
Conclusions: OK suppressed axial elongation in myopic children, suggesting that this treatment 
can slow the progression of myopia to a certain extent.  
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   Myopia is one of the most common ocular abnormalities in humans. The prevalence of 
myopia is reported to be between 25 and 30% in the developed countries1,2 with the incidence 
being higher among certain Asian populations.3 It is generally considered that progression of 
youth-onset myopia is attributable to axial length elongation, which is not compensated for by 
reductions in the corneal and crystalline lens power.4-7  
Myopia can be corrected by spectacles or contact lenses. However, these treatments do not 
solve the problem of ocular axial elongation. It is well known that myopia is often associated 
with sight-threatening complications, such as retinal detachment, macular degeneration, and 
glaucoma.8-11 Furthermore, the risk of these complications increases with the severity of myopia 
and axial length.11 Arresting the progression of this myopic condition and preventing accentuated 
myopia would therefore contribute to the prevention of these common ocular diseases, and thus 
would likely have a very significant effect in reducing medical expenditure.  
So far, the scientific community has been trying to find an effective means to slow or even 
arrest the development of myopia in children.12 A number of medical treatments have been tested, 
including topical application of tropicamide,13 atropine,14-16 pirenzepine17-19 and ocular 
hypotensive agents20,21. However, there have been no ideal therapeutic modalities to effectively 
prevent myopic progression in light of efficacy, safety, economic feasibility, and ease of 
application. 
One previous report has described the effectiveness of overnight orthokeratology (OK) for 
arresting the progression of myopia in the left eye of a 13-year-old boy, in whom it was found 
that axial elongation was less in the left eye than in the right after 2 years.22 This study showed 
the possibility that OK might be capable of suppressing ocular axial elongation in myopic 
children. Subsequently, Cho et al. conducted a 2-year pilot study to determine whether OK could 
ameliorate the progression of myopia in children.23 The authors compared the growth of axial 
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length in 35 children undergoing OK with that of 35 children wearing single vision spectacles, 
and reported that the increases in axial length were significantly smaller in the OK group than the 
spectacles group. In that study, however, the data for the control group were obtained at other 
facilities, where axial length was measured using different devices.24 Therefore, the study was not 
considered to have been adequately controlled. More recently, similar results have been 
confirmed by the study of Walline et al.25 However, it was also a non-randomized study with an 
inappropriate control group, which had been recruited from a different study.26 In addition, axial 
length measurements were performed using a conventional contact type a-scan ultrasound device. 
In recent years, it has been shown that a laser interferometer (IOLMaster, Zeiss Humphrey 
System, CA, USA) yields highly reproducible, precise, non-contact, and rapid axial length 
measurements with less burden on the patient.27 Such features of the IOLMaster are considerably 
advantageous for repeated, longitudinal measurements of axial length in children.  
We conducted the current prospective study using the IOLMaster to find out how the 
continued use of OK affects axial growth in children. Children wearing spectacles and attending 
the same clinic were recruited as controls. 
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Patients and Methods 
The survey was conducted between November 2002 and June 2007. Forty five patients who 
matched the inclusion criteria (Table 1) were enrolled in the OK group. There were 22 boys and 
23 girls, ranging in age from 8 to 16 (12.1 ± 2.5 [mean ± SD]) years. One hundred twenty eyes of 
60 individuals served as controls. They also matched the inclusion criteria for OK but preferred 
spectacles to OK for the correction of myopia. The control group included 28 boys and 32 girls, 
ranging in age from 8 to 16 (11.9 ± 2.0) years.  
The study was conducted in accordance with the tenets of the Declaration of Helsinki and 
approved by the Ethics Committee of Kakita Eye Clinic. Informed consent was obtained in 
writing from all participants and their guardians following an explanation of the nature and 
possible consequences of the study. 
The OK lenses used in this study were Emerald Lenses (Euclid Systems Corporations, 
Herndon, VA, USA), which are four-zone reverse geometry lenses manufactured from Boston 
XO material (Polymer Technology Corp., Wilmington, MA, USA) with a nominal Dk of 100 x 
10-11 (cm2/sec)(ml O2/ml・mmHg). The nominal central thickness of the lenses was 0.22 mm and 
the diameter was 10.6 mm. The patients were fitted with the lenses according to the 
manufacturer’s specification. After the lenses had been dispensed, the patients were 
recommended to wear their OK lenses every night for at least 7 consecutive hours.  
The patients in the control group wore single vision glasses, which were prescribed by a 
certified ophthalmic technician and modified according to any refractive changes during the 
follow-up period.  
The OK group returned for examination every 3 months and underwent slitlamp examinations 
for any adverse events. The OK lens fit was evaluated at these visits. The control group returned 
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for examination every 6 months. OK lenses and spectacles were replaced if visual acuity was 
found to change by more than 0.30 logMAR units during the follow-up.  
It has been reported that corneal thinning stabilizes by the end of the week following 
orthokeratology,28 or that thinning continues for one29 or two30 months. In the current study, 
therefore, axial length was measured 3 months after the start of OK, which was used as the 
baseline data for axial length. As for refraction and visual acuity, data obtained before starting 
OK were used as the baseline values. In the control group, axial length, refraction, and visual 
acuity were measured when the subject started wearing spectacles. In both groups, OK or 
spectacles were continued for 2 years, and axial length, refraction, and visual acuity were 
measured at the end of the 2-year study period (i.e. 2 years and 3 months for the OK group).  
The axial length was evaluated using a non-contact optic biometric device, IOLMaster, 
between 3 and 6 o’clock in the afternoon. On each occasion, 5 successive measurements were 
taken and their mean was used as a representative value. The measurements were performed by a 
single examiner who was blinded to the original refractive status and subjects’ assignment to 
either group. 
The changes in axial length were evaluated prospectively and compared. In each group, a 
paired t test was used to compare axial length at baseline and at 2 years after treatment. An 
unpaired t test was used to compare the changes in axial length between groups. 
 
Results 
Among the 45 patients who were enrolled initially in the OK group, 42 patients (male 21, 
female 21) successfully completed the 2-year follow-up examinations. Their ages ranged from 8 
to 16 (12.0 ± 2.6) years. Thirteen patients (31%) were aged 8 to 10 years, 23 (55%) were aged 11 
to 13 years, and 6 (14%) were aged 14 to 16 years. At baseline, their spherical equivalent 
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refractive error ranged from -0.50 to -10.00 (-2.55 ± 1.82) D; logMAR uncorrected visual acuity 
was between 0.30 and 1.40 (0.80 ± 0.32), and axial length ranged from 21.98 to 27.67 (24.66 ± 
1.11) mm (Table 2). Three patients in the OK group dropped out of the study due to insufficient 
improvement in uncorrected visual acuity (2 patients) and loss to follow-up.  
Among the 60 patients in the spectacle control group, 50 patients (male 22, female 28) 
successfully completed the 2-year follow-up examinations. Their ages ranged from 8 to 16 (11.9 
± 2.1) years. Seventeen patients (34%) were aged 8 to 10 years, 26 (52%) were aged 11 to 13 
years, and 7 (14%) were aged 14 to 16 years. At baseline, their spherical equivalent refractive 
errors were between -0.50 and -9.00 (-2.59 ± 1.66) D; logMAR uncorrected visual acuity ranged 
from 0.10 to 1.40 (0.83 ± 0.31), and axial length ranged from 22.53 to 28.00 (24.79 ± 0.80) mm 
(Table 2). Ten patients in the control group missed follow-up examinations and dropped out of 
the study. 
At baseline, the two groups were comparable in terms of spherical equivalent refractive error, 
uncorrected visual acuity, axial length, age (unpaired t test), and gender distribution 
(Mann-Whitney U test) (Table 2). There were also no significant differences in age distribution 
(8-10, 11-13, and 14-16 years) between the groups. In the OK group, spherical equivalent 
refractive error decreased significantly from -2.55 ± 1.82 D at baseline to -0.68 ± 1.02 D at 2 
years after the treatment (paired t test, p < 0.0001). In the control group, refractive error increased 
significantly from -2.59 ± 1.66 D to -3.83 ± 1.76 D (p < 0.0001).  
In 2 years, axial length increased from 24.66 ± 1.11 mm to 25.05 ± 1.06 mm in the OK group 
and from 24.79 ± 0.80 to 25.40 ± 0.84 mm in the spectacle control group. In both groups, 
significant elongation of axial length was recognized during 2 years (p < 0.0001). The increases 
in axial length were 0.39 ± 0.27 mm and 0.61 ± 0.24 mm in the OK and spectacle groups, 
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respectively, and the increase in the OK group was significantly smaller than that in the spectacle 
group (unpaired t test, p < 0.0001). 
Increases in axial length were analyzed in relation to the spherical equivalent refractive error 
at baseline. A significant correlation was found between these parameters in the OK group 
(Pearson’s correlation coefficient; r = 0.290, p = 0.0076), but not in the control group (r = 0.038, 
p = 0.7090) (Fig. 1, 2). 
In the OK group, 2 patients developed mild corneal erosion, which improved after one week 
of treatment cessation, and subsequent OK treatment was resumed without any sequelae. No 
other complications, such as corneal ulcer, were noted. There were no adverse events in the 
spectacle group. 
 
Discussion  
In 2005, Cho et al. reported that axial length in children elongated over a 2-year-period by 
0.29 ± 0.27 mm in an OK-treated group and by 0.54 ± 0.27 mm in a control group treated with 
spectacles.23 In 2009, Walline et al. reported similar findings; the mean axial length elongation in 
2 years was 0.25 mm in the OK group and 0.57 mm in the control group.25 Although similar 
results were obtained in our study, our subjects showed slightly greater axial length elongation in 
2 years, being 0.39 ± 0.27 mm in the OK group vs. 0.61 ± 0.24 mm in the control group.  
There were several limitations to the study conducted by Cho et al.23 First, they used a contact 
type ultrasonic A-mode device to measure the axial length. It is difficult to measure axial length 
precisely with proper fixation and no indentation in children between 7 and 12 years. Second, the 
data of the control spectacles-wearing group were taken from another study conducted by 
Edwards et al.,24 in which a different ultrasonic device was used to measure axial length. 
Naturally, different examiners conducted the measurements in a non-masked way. Third, axial 
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length at the start of OK was used as the baseline data. It has been reported that the central 
corneal thinning caused by OK ranges from -12 to -19 µm over a span of 3 months.28,30,31 This 
thinning is considered to be the epithelium in origin, while stromal change is negligible.31 
Furthermore, OK does not alter the posterior corneal curvature or the anterior chamber depth.32 
Thus, corneal thinning due to OK is attributable to epithelial changes, which can confound the 
study results. The study by Walline et al.25 also had similar weaknesses. 
In the current study, the IOLMaster, a laser interferometer, was used to conduct non-contact 
measurements of axial length. This device is very suitable for axial length measurements in 
children thanks to its high reproducibility, precision, lack of direct contact, and rapidity.27 
Moreover, both the OK and spectacle groups in our study were examined at a single center, by a 
single examiner, using a single instrument. Because the axial length taken 3 months after the start 
of OK was used as the baseline data, any initial corneal flattening by OK was excluded from the 
analysis of changes in axial length. Our improved study design allowed us to demonstrate that 
OK significantly slowed the elongation of axial length in myopic children. 
Little is known about how OK retards axial elongation in childhood myopia. It has been 
postulated that growth of the eye is modulated by a visual feedback response to the defocus 
produced by the eye’s refractive state.33,34 Recently, some experimental studies of primates have 
yielded data to support the concept that peripheral retina is able to influence ocular growth and 
refractive development.35-38 Similarly in humans, it is known that peripheral retina can influence 
refractive development, e.g., retinal diseases that affect mainly the peripheral retina,39,40 and that 
peripheral laser photocoagulation for retinopathy of prematurity41,42 is often associated with 
significant refractive errors. Mutti et al.43,44 reported that myopic children had greater relative 
hyperopia in the periphery with respect to axial refraction, indicating a prolate ocular shape (an 
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axial length exceeding the equatorial diameter), as compared with relative peripheral myopia and 
an oblate shape (an equatorial diameter exceeding the axial length) for emmetropes and 
hyperopes, suggesting that hyperopic defocus in the periphery promotes axial myopia in humans. 
Treatment strategies and methods for correcting not only central refractive error but also 
peripheral defocus and image quality may be effective to control eye growth in myopic 
children.35,45 From this viewpoint, OK seems to be a promising method, inducing a reduction in 
central epithelial thickness and an increase in the more peripheral annular zone to yield a flatter 
central area.30,46  
Although these corneal changes eliminate myopic refractive error in the central area, there is 
probably an increase of myopia in intermediate peripheral areas caused by the annular ridge of 
epithelial and stromal thickening.47 Therefore, light passing through the flattened central area of 
the cornea forms an image on the fovea, while light passing through the mid-peripheral cornea, 
which became steeper than the original shape after OK, focuses at a point closer to the retina at 
the periphery. In other words, this type of corneal morphology can eliminate or decrease relative 
peripheral hyperopia that is often associated with myopic eyes.48 At this stage, however, this 
hypothesis remains speculative, and will need to be tested by detailed evaluation of ocular shape 
and peripheral refractive status before and after the start of OK, in addition to the parameters we 
examined in the present study. In addition, it may be useful to examine the relationship between 
peripheral aberrations and axial elongation, because substantial increases in higher-order 
aberrations after OK were observed also in the peripheral field of the eye.48 
There was a significant relationship between the increases in axial length and baseline 
refractive errors in the OK group, whereas this relationship was not significant in the control 
group. When compared between the two scatterplots (Fig. 1&2), the distributions of axial growth 
were similar in both groups for low baseline myopes, showing a wide variety of increases in axial 
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length. However, the distributions were different for high baseline myopes. The increases in axial 
length were much smaller in the OK group than in the spectacle group. This indicates that when 
the baseline myopia is more severe, the axial elongation after OK is less marked. Generally, the 
cornea becomes more oblate (with a flat central area and increasing power toward the periphery) 
when more severe myopia is corrected by OK lenses with a very flat base curve. This probably 
leads to a greater decrease of hyperopic defocus at the periphery, thus exerting a greater 
suppressive effect on axial growth. 
Although almost all subjects were adequately treated by OK, the myopic refractive error of 
only one subject (12-year-old boy) was not sufficiently corrected over the 2-year study period. 
The original refractive error of this case was -10.0 and -8.75 D in the right and left eyes, 
respectively, and these myopic refractive errors were the largest in the OK group. The 2-year 
treatment of OK improved these refractive errors from -10.0 to -4.0 D and from -8.75 to -2.0 D in 
the right and left eyes, respectively. LogMAR uncorrected visual acuity was also improved from 
1.398 to 0.523 in the right eye, and from 1.222 to 0.155 in the left eye. Despite the fact that his 
refractive error after the treatment was not emmetropia and his visual acuity did not reach 20/20 
(0.00 logMAR) in both eyes, he was satisfied with his visual outcomes and able to perform his 
daily activities without additional spectacle corrections. In this case, the increase in axial length 
during the 2-year study period was 0.13 and 0.27 mm in the right and left eyes, respectively, 
showing much smaller axial elongation in comparison to that in the spectacle group. This fact 
may support the concept that improvement in peripheral refractive status itself exerts a 
suppressive effect on axial growth even if the central refraction is not fully corrected. However, 
the peripheral refractive status of this subject is unknown. Further studies are needed to 
investigate whether elimination or reduction in hyperopic defocus in the periphery without 
enough correction in the central retina can retard axial elongation in childhood myopia. 
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In conclusion, our study has demonstrated a significant elongation of axial length in two 
groups of children treated with OK and with spectacles over a 2-year period. However, the axial 
length elongation in the OK group was significantly smaller than that in the controls. The mean 
axial growth rate was 0.15 mm per year in the OK group and 0.30 mm per year in the spectacle 
control group: a very marked difference. Although OK cannot completely arrest axial elongation 
in myopic children, it can retard such elongation to a certain extent, suggesting the potential of 
this treatment for slowing the progression of myopia. 
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Figure Legends 
 
Figure 1. Scatterplots demonstrating increases in axial length and spherical equivalent refractive 
errors at the baseline in the OK group. 
A significant correlation was found between the increases in axial length and spherical equivalent 
refractive errors at the baseline (Pearson’s correlation coefficient; r = 0.290, p = 0.0076). 
 
Figure 2. Scatterplots demonstrating increases in axial length and spherical equivalent refractive 
errors at the baseline in the spectacle group. 
No significant correlation was observed between the increases in axial length and spherical 
equivalent refractive errors at the baseline (Pearson’s correlation coefficient; r = 0.038, p = 
0.7090).
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Table 1. Inclusion criteria 
1. Ages from 8 to 16 years at the baseline. 
2. No history of orthokeratology or the use of contact lenses. 
3. Non-cycloplegic autorefraction (spherical equivalent) from -10.00 to -0.50 D in both eyes. 
4. Astigmatism (non-cycloplegic autorefraction) equal to or less than 1.50 D in both eyes. 
5. Anisometropia (non-cycloplegic autorefraction) equal to or less than 1.50 D. 
6. Best-corrected visual acuity being equal to or better than 0.00 logMAR units in both eyes 
(Snellen equivalent to 20/20). 
7. No strabismus by a cover-uncover test either with or without refractive correction. 
8. Birth weight equal to or more than 1,250 g. 
9. No known ocular, systemic or neurodevelopmental deviations that might affect refractive 
development. 
10. No use of medications that might affect refractive development. 
D = diopter, logMAR = logarithm of the minimum angle of resolution. 
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Table 2. Baseline data of patients who completed 2-year follow-up examinations in the OK and 
control groups 
 Orthokeratology 
(mean±SD) 
Control 
(mean±SD) P value 
Age (years) 12.0±2.6 11.9±2.1 p=0.6129 
Gender Male 21, Female 21 Male 22, Female 28 p*=0.4378 
Spherical equivalent 
refractive error (D) -2.55±1.82 -2.59±1.66 p=0.8771 
Uncorrected visual 
acuity(logMAR) 0.80±0.32 0.83±0.31 p=0.5064 
Axial length(mm) 24.66±1.11 24.79±0.80 p=0.3434 
 
SD = standard deviation, D = diopter,  
LogMAR = logarithm of the minimum angle of resolution. 
p = probability values using unpaired t test. 
p*= probability values using Mann-Whitney U test. 
No significant inter-group differences or variations in distribution patterns at the baseline in 
spherical equivalent refractive error, uncorrected visual acuity, axial length, age or gender.  
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